Femasys Inc. Company Profile
NASDAQ: FEMYHealthcareMedical Instruments & SuppliesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Femasys at a glance
Femasys Inc. (NASDAQ: FEMY) is a Medical Instruments & Supplies company in the Healthcare sector headquartered in Suwanee, GA. Femasys is led by Ms. Kathy Lee-Sepsick M.B.A. and employs about 51 people. The company's shares have traded publicly since 2021.
At a market capitalization of $17.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001339005, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Femasys do?
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Business description based on the company's public filings.
Company information
- Legal name
- Femasys Inc.
- Ticker
- NASDAQ: FEMY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Ms. Kathy Lee-Sepsick M.B.A.
- Employees
- 51
- Headquarters
- 3950 Johns Creek Court, Suwanee, GA, United States
- Phone
- 770 500 3910
- Website
- femasys.com
- IPO year
- 2021
- Market cap
- $17.13M
- SEC CIK
- 0001339005
Companies similar to Femasys
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BNGOBionano Genomics Inc. | 1.46 | 0.00% | $17.19M | vs FEMY |
| RVPRetractable Technologies Inc. | 0.662 | -4.17% | $19.82M | vs FEMY |
| CUPRCuprina Holdings (Cayman) Limited Class A | 1.90 | -4.52% | $13.31M | vs FEMY |
| RGNTRegentis Biomaterials Ltd. | 1.70 | +4.29% | $11.94M | vs FEMY |
| LUCYInnovative Eyewear Inc. | 0.8967 | -1.68% | $7.81M | vs FEMY |
| MLSSMilestone Scientific Inc. | 0.36 | -2.70% | $32.62M | vs FEMY |
| NXGLNexGel Inc | 0.15 | -15.35% | $1.46M | vs FEMY |
| NEPHNephros Inc. | 3.29 | +2.81% | $35.73M | vs FEMY |